CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- FWP Offering Free Writing Prospectus
- 4 Grant or award Chief Executive Officer acquired 217,500 shares (grant or award)
- 4 Grant or award Principal Accounting Officer acquired 55,555 shares (grant or award)
- 4 Grant or award CFO & Chief Business Officer acquired 44,567 shares (grant or award)
- 8-K Event Executive or director change
- 8-K Event Material agreement · Results of operations · Regulation FD disclosure · Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market sale Principal Accounting Officer sold 9,446 shares at an average $2.61 ($24,666)
- 4 Open-market sale CFO & Chief Business Officer sold 29,251 shares at $2.66 ($77,948)
- 4 Open-market sale Chief Executive Officer sold 72,606 shares at $2.66 ($193,473)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 1 of 32 · 631 filings